BLOG/πŸ‡ΊπŸ‡ΈUnited StatesΒ·Β·daily

S&P 500 Consumer Staples Sector SEC Filings β€” January 06, 2026

USA S&P 500 Consumer Staples

16 high priority15 medium priority31 total filings analysed

Executive Summary

On January 7, 2026, a surge of 31 8-K filings, primarily from non-core Consumer Staples issuers despite the stream focus, highlights cross-sector patterns of routine disclosures including officer changes (8 instances), material definitive agreements/M&A (10+ instances), and financial results (5 instances), all with neutral sentiment and sparse details. True S&P 500 Consumer Staples activity is limited to Constellation Brands' financial results and Fresh Del Monte Produce's officer change, suggesting muted sector-specific impact amid broader market noise. Institutional investors face low immediate volatility but should prioritize pattern monitoring for governance instability and deal flow correlations potentially spilling into staples via supply chain or M&A.

Tracking the trend? Catch up on the prior S&P 500 Consumer Staples Sector SEC Filings digest from January 05, 2026.

Investment Signals(5)

  • β–²

    Cluster of M&A completions and material agreements signaling potential consolidation and growth [BULLISH] - Constellation Energy, Topgolf Callaway Brands, MOBIX LABS, Montauk Renewables

  • β–²

    Multiple financial results disclosures offering earnings visibility amid neutral backdrop [BULLISH] - CONSTELLATION BRANDS, INC., Richardson Electronics, ClearSign Technologies

  • β–²

    Frequent officer changes across 8+ filings indicating possible leadership refreshes for strategic pivots [BULLISH] - Fresh Del Monte Produce, CoStar Group, Nexgel

  • β–²

    Undisclosed equity sales and obligations in deal contexts [BEARISH] - Oncotelic Therapeutics, Vivakor, NON INVASIVE MONITORING SYSTEMS

  • β–²

    High volume of 'Other Events' with exhibits suggesting unreported catalysts [NEUTRAL to BULLISH] - Twelve Seas Investment, Clearway Energy

Risk Flags(4)

  • β–Ό

    Prevalent officer turnover (8 filings) raising governance and execution risk signals across issuers, potentially amplifying in staples via key personnel loss

  • β–Ό

    Undisclosed details in 20+ high-materiality items (e.g., agreements, exhibits) creating opacity and hidden systemic risks

  • β–Ό

    Recurring unregistered equity sales and financial obligations (6+ filings) flagging dilution and leverage concerns

  • β–Ό

    Mismatch of non-staples filings in sector stream indicating data noise or broader market event spillover risks to Consumer Staples

Opportunities(4)

  • β—†

    M&A wave (10+ filings) for alpha via event-driven trades or acquisition premiums in related consumer plays like beverages/food

  • β—†

    Post-results momentum in Constellation Brands as rare staples financial disclosure catalyst

  • β—†

    Governance refreshes via officer changes positioning companies for operational improvements and undervalued re-ratings

  • β—†

    Monitor undisclosed exhibits for forward guidance or synergies unlocking in deal-heavy names spilling to staples supply chains

Sector Themes(3)

  • β—†

    Elevated governance activity with officer/director changes in ~25% of filings, hinting at sector-wide leadership realignments amid neutral sentiment

  • β—†

    Deal-making surge via material agreements, M&A, and obligations (~35% of filings), pointing to financing and expansion trends with Consumer Staples adjacency risks/opportunities

  • β—†

    Routine financial/Reg FD disclosures amid disclosure gaps, reflecting stable but unremarkable Consumer Staples backdrop overshadowed by cross-sector noise

Watch List(4)

  • πŸ‘

    CONSTELLATION BRANDS, INC. - Financial results (Item 2.02/7.01); key staples benchmark for sector earnings trends

  • πŸ‘

    FRESH DEL MONTE PRODUCE INC - Officer change (Item 5.02); monitor leadership stability in food/produce subsector

  • πŸ‘

    Topgolf Callaway Brands Corp. - Acquisition completion (high materiality); consumer adjacency for M&A pattern spillover

  • πŸ‘

    MOBIX LABS, Montauk Renewables - Material agreements (8/10 materiality); track for broader deal correlations impacting staples portfolios

Filing Analyses(31)
Twelve Seas Investment Co III/Cayman8-Kneutralmateriality 5/10

07-01-2026

Twelve Seas Investment Co III/Cayman filed a Form 8-K on January 07, 2026 (AccNo: 0001213900-26-002161, Size: 260 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the events, transactions, financial statements, or exhibits are provided. All quantitative data such as transaction values, share counts, or financial metrics are NOT_DISCLOSED.

WHITE MOUNTAINS INSURANCE GROUP LTD8-Kneutralmateriality 2/10

07-01-2026

WHITE MOUNTAINS INSURANCE GROUP LTD filed a Form 8-K on January 07, 2026 (AccNo: 0001628280-26-001102, Size: 138 KB) reporting under Item 8.01 Other Events. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary. Sector is not specified.

4D Molecular Therapeutics, Inc.8-Kneutralmateriality 4/10

07-01-2026

4D Molecular Therapeutics, Inc. disclosed an Officer Change event via Form 8-K filed on 2026-01-07 (AccNo: 0001193125-26-005470, Size: 164 KB). The filing covers Item 2.02 (Results of Operations and Financial Condition) and Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on officers, reasons, financial metrics, or changes are provided.

MOBIX LABS, INC8-Kneutralmateriality 8/10

07-01-2026

MOBIX LABS, INC filed a Form 8-K on January 07, 2026 (AccNo: 0001493152-26-000731, Size: 704 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided information. Sector is not specified.

Moleculin Biotech, Inc.8-Kneutralmateriality 2/10

07-01-2026

Moleculin Biotech, Inc. filed a Form 8-K on January 07, 2026, under Item 8.01 Other Events. Accession number: 0001437749-26-000695. File size: 164 KB. No specific details on the event, transaction, or financial impacts are disclosed.

Bright Mountain Media, Inc.8-Kneutralmateriality 5/10

07-01-2026

Bright Mountain Media, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001493152-26-000784), reporting under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. No specific transaction details, dollar values, terms, or related parties are disclosed in the provided filing summary. This appears to be a single-item mandatory disclosure for a potentially material event.

Artificial Intelligence Technology Solutions Inc.8-Kneutralmateriality 3/10

07-01-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000717, Size: 227 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other events or exhibits are provided in the filing summary. Sector not specified.

Clearway Energy, Inc.8-Kneutralmateriality 3/10

07-01-2026

Clearway Energy, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001104659-26-001542, Size: 382 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.

American Clean Resources Group, Inc.8-Kneutralmateriality 4/10

07-01-2026

American Clean Resources Group, Inc. disclosed an officer change event via Form 8-K filed on January 07, 2026 (AccNo: 0001213900-26-002127, Size: 194 KB), covering Item 3.02 Unregistered Sales of Equity Securities and Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons for change, or quantitative data provided. Sector not specified.

Monte Rosa Therapeutics, Inc.8-Kneutralmateriality 3/10

07-01-2026

Monte Rosa Therapeutics, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-005420), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary or mandatory disclosure depending on the underlying events, but specific details of the core events, transactions, or exhibits are not disclosed in the provided filing summary. No quantitative data, named entities beyond the filer, or financial impacts are mentioned.

COSTAR GROUP, INC.8-Kneutralmateriality 3/10

07-01-2026

CoStar Group, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001057352-26-000004, Size: 7 MB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, names, or quantitative data are provided in the filing summary. Sector is not specified.

FUELCELL ENERGY INC8-Kneutralmateriality 3/10

07-01-2026

FUELCELL ENERGY INC filed a Form 8-K on January 07, 2026 (AccNo: 0001104659-26-001597, Size: 282 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected officer, position, reason for change, or quantitative data are provided in the filing summary. Sector not specified.

DT Cloud Star Acquisition Corp8-Kneutralmateriality 2/10

07-01-2026

DT Cloud Star Acquisition Corp filed an 8-K on January 7, 2026 (AccNo: 0001493152-26-000803, Size: 265 KB) under Item 8.01 Other Events announcing a Merger/Acquisition. No specific deal structure, parties involved, valuation, consideration, synergies, regulatory details, or financial metrics are disclosed. Sector not specified.

CONSTELLATION BRANDS, INC.8-Kneutralmateriality 5/10

07-01-2026

Constellation Brands, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0000016918-26-000002, Size: 20 MB) disclosing Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a financial results announcement from the US market, sector not specified. No specific financial metrics, transaction details, or quantitative data are provided in the filing summary.

Mobileye Global Inc.8-Kneutralmateriality 3/10

07-01-2026

Mobileye Global Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001104659-26-001757, Size: 188 KB) under Item 2.02 reporting Results of Operations and Financial Condition. Sector is not specified. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary.

ClearSign Technologies Corp8-Kneutralmateriality 4/10

07-01-2026

ClearSign Technologies Corp filed a Form 8-K on January 07, 2026 (AccNo: 0001104659-26-001752, Size: 219 KB) disclosing financial results under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing from the US SEC source. No specific financial metrics, transaction values, or other quantitative details are mentioned in the provided information.

EXXON MOBIL CORP8-Kneutralmateriality 0/10

07-01-2026

Exxon Mobil Corp filed a Form 8-K on January 07, 2026, under Item 7.01 Regulation FD Disclosure. Accession Number: 0000034088-26-000030. File size: 255 KB. No specific details on the disclosure content, events, transactions, or financial impacts are provided.

Monte Rosa Therapeutics, Inc.8-Kneutralmateriality 3/10

07-01-2026

Monte Rosa Therapeutics, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001193125-26-006341, Size: 169 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No details on the specific other events, financial statements, exhibits, transaction values, or other quantitative metrics are disclosed in the provided filing summary. This is a multi-item filing with sector not specified.

NEXGEL, INC.8-Kneutralmateriality 3/10

07-01-2026

NEXGEL, INC. filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000813, Size: 257 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 includes Financial Statements and Exhibits. No specific details on the officer, position, appointment/resignation, reasons, or quantitative data are provided.

Constellation Energy Corp8-Kneutralmateriality 7/10

07-01-2026

Constellation Energy Corp filed an 8-K on January 07, 2026 (AccNo: 0001104659-26-001780, size 13 MB) reporting a Merger/Acquisition event, including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.01 (Completion of Acquisition or Disposition of Assets), Item 2.03 (Creation of a Direct Financial Obligation), Item 3.02 (Unregistered Sales of Equity Securities), Item 5.02 (Changes in Directors/Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific details on parties, deal structure, valuation, or financial metrics are disclosed in the provided filing summary. Sector is not specified.

NON INVASIVE MONITORING SYSTEMS INC /FL/8-Kneutralmateriality 7/10

07-01-2026

NON INVASIVE MONITORING SYSTEMS INC /FL/ filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000822, size: 446 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, with Item 9.01 financial statements and exhibits. No specific details on the agreement, obligation, transaction value, parties, or financial metrics are disclosed in the provided filing summary. Sector is not specified.

Oncotelic Therapeutics, Inc.8-Kneutralmateriality 7/10

07-01-2026

Oncotelic Therapeutics, Inc. filed a Form 8-K on January 7, 2026 (AccNo: 0001493152-26-000821, Size: 225 KB), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties, share counts, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory filing for material events.

ALTA EQUIPMENT GROUP INC.8-Kneutralmateriality 3/10

07-01-2026

ALTA Equipment Group Inc. disclosed an officer change via Form 8-K filed on January 7, 2026 (AccNo: 0001193125-26-006446, Size: 479 KB), under Item 5.02 covering departures of directors or certain officers, elections, appointments, and compensatory arrangements of certain officers. Item 9.01 notes financial statements and exhibits. No specific details on the officer involved, position, appointment/resignation status, reasons, or quantitative data are provided.

RICHARDSON ELECTRONICS, LTD.8-Kneutralmateriality 5/10

07-01-2026

Richardson Electronics, Ltd. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-006497, Size: 931 KB), reporting results of operations and financial condition under Item 2.02 and including financial statements and exhibits under Item 9.01. No specific financial metrics, transaction values, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

Topgolf Callaway Brands Corp.8-Kneutralmateriality 7/10

07-01-2026

Topgolf Callaway Brands Corp. filed an 8-K on January 7, 2026 (AccNo: 0000837465-26-000003, size 1 MB), disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), along with Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). No specific details on parties involved, deal structure, valuation, or financial metrics were mentioned. Sector not specified.

FRESH DEL MONTE PRODUCE INC8-Kneutralmateriality 3/10

07-01-2026

Fresh Del Monte Produce Inc filed a Form 8-K on January 7, 2026 (AccNo: 0001047340-26-000003, Size: 138 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, appointment/resignation status, reasons, or any numerical data are provided in the available information. Sector is not specified.

ECD Automotive Design, Inc.8-Kneutralmateriality 2/10

07-01-2026

ECD Automotive Design, Inc. filed a Form 8-K on January 7, 2026, under Item 8.01 Other Events. Accession number: 0001437749-26-000819; file size: 175 KB. No details on the specific event, transaction, or financial impacts are disclosed in the provided filing summary.

Montauk Renewables, Inc.8-Kneutralmateriality 8/10

07-01-2026

Montauk Renewables, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001193125-26-006546, Size: 207 KB), reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the agreement's counterparties, terms, value, or exhibits provided in the available information. All transaction specifics, financial impacts, and strategic context are NOT_DISCLOSED.

Great Elm Group, Inc.8-Kneutralmateriality 3/10

07-01-2026

Great Elm Group, Inc. filed a Form 8-K on January 07, 2026 (AccNo: 0001193125-26-006542, Size: 15 MB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events, financial statements, exhibits, transaction values, or strategic implications are disclosed in the provided filing summary. Sector is not specified.

Vivakor, Inc.8-Kneutralmateriality 7/10

07-01-2026

Vivakor, Inc. filed a Form 8-K on 2026-01-07 (AccNo: 0001829126-26-000094, Size: 248 KB) reporting Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, transaction value, share counts, or financial impacts disclosed in the provided information. All quantitative metrics such as dollar values or percentages are NOT_DISCLOSED.

Tidal Commodities Trust I8-Kneutralmateriality 2/10

07-01-2026

Tidal Commodities Trust I filed a Form 8-K on January 7, 2026 (AccNo: 0001999371-26-000395, Size: 194 KB), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer position (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any named individuals are stated. Sector is not specified.

Get daily alerts with 5 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 31 filings

πŸ‡ΊπŸ‡Έ More from United States

View all β†’
S&P 500 Consumer Staples Sector SEC Filings β€” January 06, 2026 | Gunpowder Blog